Jazz Pharmaceuticals plc Business Combination, Acquired Receivables, Gross Contractual Amount
Jazz Pharmaceuticals plc (JAZZ) had Business Combination, Acquired Receivables, Gross Contractual Amount of $14.90 million as of 2013-12-19, per its 10-Q filed 2014-05-08.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Acquired Receivable, Purchased without Credit Deterioration, and Acquired Net Investment in Lease
us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount · last filed 2014-05-08
- 2013-12-19: Business Combination, Acquired Receivables, Gross Contractual Amount $14.90M.
| Period end | Business Combination, Acquired Receivables, Gross Contractual Amount |
|---|---|
| 2013-12-19 | $14.90M 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |